Brief: Satsuma Pharmaceuticals Posts Q2 Loss Per Share Of $0.38
10/08/2021 22:46
Aug 10 (Reuters) - Satsuma Pharmaceuticals Inc STSA.O :
* SATSUMA PHARMACEUTICALS REPORTS SECOND QUARTER 2021
FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
* SATSUMA PHARMACEUTICALS INC - NET LOSSES FOR THE SECOND
QUARTER
OF 2021 WERE $11.8 MILLION, OR $0.38 PER COMMON SHARE
Source text for Eikon: ID:nGNX3BQ9Bc
Further company coverage: STSA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Satsuma Pharmaceuticals
See all newsBrief: Satsuma Pharmaceuticals Announces FDA Acceptance Of 505(B)(2) NDA For Sts101, A Novel And Investigational Dihydroergotamine Nasal Powder Product For The Acute Treatment Of Migraine
Commencement Of Tender Offer For Satsuma Pharmaceuticals, Inc In U.S.
Brief: Satsuma Pharmaceuticals Says Received Letter Notifying Co Regained Compliance With Nasdaq
U.S. STOCKS ON THE MOVE-Alphabet Inc, BlackRock, Moderna
Satsuma Pharma soars on buyout deal from Japan's Shin Nippon